Sarah McHatton
Vice President, Global Research & Development & Regulatory Affairs Valent BioSciences
Sarah McHatton is Valent BioSciences’ Vice President for Global R&D and Regulatory Affairs, leading research, development, and regulatory strategies. With expertise in microbiology and fermentation, she has experience advancing products from discovery to commercialization. Previously, McHatton led R&D for biocontrol and biofertility at Novozymes, managing the BioAg Applications Research team and serving as site lead in Research Triangle Park, NC. She also has experience in biofuels, household care, and medical diagnostics R&D. McHatton holds a Ph.D. and M.S. in microbiology from UC-Davis and a B.S. in biology from the University of Michigan.
Seminars
Getting biological products to market quickly—and successfully—starts with smart decisions early in development. This workshop will show you how to identify scalable ideas, anticipate manufacturing challenges, and build a regulatory strategy that accelerates your path to commercialization. Learn how to reduce risk, cut unnecessary costs, and move confidently from concept to market-ready product.
- Filter high-potential ideas by prioritizing those with clear scalability and realistic production paths
- Integrate early manufacturability checks to catch cost or feasibility issues before investing in field trials
- Build cross-functional teams to surface regulatory, technical, and production risks early in development
- Explore the regulatory data required for product registration and how to engage with agencies effectively to minimize delays
- Examine the safety and distribution of microbes, particularly in relation to human health and plant pests
